Protective role of Decylubiquinone against secondary melanoma at lung in B16F10 induced mice by reducing E-cadherin expression and ameliorating ROCKII-Limk1/2-Cofiliin mediated metastasis

Melanoma is one of the most consequential skin cancer with a rising death incidences. Silent but belligerent nature of metastatic sprouting is the leading cause of melanoma related mortality. Invasion of metastatic cells and re-expression of E-Cadherin play the crucial role in the establishment of s...

Full description

Saved in:
Bibliographic Details
Published inCellular signalling Vol. 101; p. 110486
Main Authors Chatterjee, Sujan, Patra, Debajyoti, Ghosh, Pujita, Banerjee, Soumi, Mishra, Snehasis, Chakraborty, Pratip, Chowdhury, Kaustav Dutta, Basu, Anupam, Sadhukhan, Gobinda Chandra
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Melanoma is one of the most consequential skin cancer with a rising death incidences. Silent but belligerent nature of metastatic sprouting is the leading cause of melanoma related mortality. Invasion of metastatic cells and re-expression of E-Cadherin play the crucial role in the establishment of secondary tumor at distal sites. Thus, manipulation of tumor cell invasion in parallel to regulation of E-Cadherin expression can be considered as potential anti-metastatic strategy. Evidences suggested key role of reactive oxygen species associated ROCK activities in the modulation of metastatic invasion via F-actin stabilization. Here, we first-time report Decylubiquinone, a dietary Coenzyme Q10 analog, as an effective attenuator of pulmonary metastatic melanoma in C57BL/6 mice. Current study depicted detailed molecular interplay associated with Decylubiquinone mediated phosphorylation of ROCKII at Tyr722 along with reduced phosphorylation of ROCKII Ser1366 leading to suppression of Limk1/2-Cofilin-F-actin stabilization axis that finally restricted B16F10 melanoma cell invasion at metastatic site. Analysis further deciphered the role of HNF4α as its nuclear translocation modulated E-Cadherin expression, the effect of reactive oxygen species dependent ROCKII activity in secondarily colonized B16F10 melanoma cells at lungs. Thus unbosoming of related signal orchestra represented Decylubiquinone as a potential remedial agent against secondary lung melanoma. [Display omitted] •Decylubiquinone (Dub) mitigates B16F10 induced secondary lung melanoma.•Dub calibrates intercellular ROS level and modulates ROCKII activity in melanoma.•Dub mediated deactivation of ROCKII attenuates Limk1/2-Cofilin-Factin stabilization.•Dub censors E-Cadherin re-expression by restricting HNF4α/ID1 nuclear translocation.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0898-6568
1873-3913
1873-3913
DOI:10.1016/j.cellsig.2022.110486